Document Type

Article

Publication Date

9-30-2021

Comments

This article is the author’s final published version in Advanced Ultrasound in Diagnosis and Therapy, Volume 5, Issue 3, September 2021, Pages 254-257

The published version is available at https://doi.org/10.37015/AUDT.2021.210018. Copyright © AUDT

Abstract

Minimally invasive locoregional therapies have become important treatment options for patients with intermediate or late-stage hepatocellular carcinoma (HCC) who are ineligible for surgical resection or liver transplantation. Imaging modalities are essential for procedural guidance and for assessing treatment response thereafter. We report a unique finding of a patient with multifocal HCC treated with transarterial radioembolization (TARE) with yttrium-90 (Y90) and transarterial chemoembolization (TACE). We compared contrast-enhanced ultrasound (CEUS) with contrast-enhanced magnetic resonance imaging (CE-MRI) in the evaluation of treatment response to demonstrate advantages of CEUS imaging technique and its early detection of viable tumor.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English

Included in

Radiology Commons

Share

COinS